Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 4/20 | 0.51 |
| ▸ | BACE1 | P56817 | 6/20 | 0.51 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.49 |
| ▸ | GNPAT | O15228 | 1/20 | 0.47 |
| ▸ | ACE | P12821 | 2/20 | 0.47 |
| ▸ | CPA1 | P15085 | 2/20 | 0.47 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.47 |
| ▸ | CTSD | P07339 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29381316 | 0.94 | MME (0.55) | MMEBACE1NAALAD2GNPATACE | |
| SCHEMBL8821945 | 0.94 | MME (0.55) | MMEBACE1NAALAD2GNPATACE | |
| SCHEMBL2980533 | 0.94 | MME (0.57) | MMEBACE1NAALAD2ACECPA1 | |
| SCHEMBL5970186 | 0.94 | MME (0.57) | MMEBACE1NAALAD2ACECPA1 | |
| SCHEMBL30903452 | 0.93 | BACE1 (0.57) | MMEBACE1NAALAD2CTSD | |
| SCHEMBL29603611 | 0.91 | NAALAD2 (0.60) | MMEBACE1NAALAD2CTSD | |
| SCHEMBL29531169 | 0.91 | NAALAD2 (0.60) | MMEBACE1NAALAD2CTSD | |
| SCHEMBL29603574 | 0.91 | NAALAD2 (0.60) | MMEBACE1NAALAD2CTSD | |
| SCHEMBL31474554 | 0.91 | BACE1 (0.56) | MMEBACE1NAALAD2GNPATCTSD | |
| SCHEMBL29725302 | 0.91 | BACE1 (0.54) | MMEBACE1GNPATCTSD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4370150-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | Intervet International B.V. (NL) | 2024-05-22 | — | — | EP | disclosed |
| WO-2023285489-A1 | OVERCOMING ANTIBODY-INTERFERENCE IN AVIANS | INTERVET INTERNATIONAL B.V. (NL) | 2023-01-19 | — | — | WO | disclosed |